Xtant Medical Holdings (XTNT) Misses Q4 EPS by 1c

Xtant Medical Holdings (NYSE: XTNT) reported Q4 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $31.51 million versus the consensus estimate of $31.8 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Chardan Starts Odysight.AI Inc. (ODYS) at Buy